Lamzede 10 mg, poudre pour solution pour perfusion - 5 Swissmedic Key 68591002 Registration Holder Chiesi SA Name Lamzede 10 mg, poudre pour solution pour perfusion Date of registration 26.08.2022 Introduction of Sequence 26.08.2022 ATC-Classification Velmanase Alfa (A16AB15) Revision date WHO WHO-DDD Valid until 25.08.2029 Index Therapeuticus (BSV) Show package size 5 Index Therapeuticus (Swissmedic) 07.14. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680685910028 Medication Code Biotechnologika Pharmacode Disponibility
Composition velmanasum alfa 10 mg, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, mannitolum, glycinum, pro vitro corresp. natrium 0.817 mg. Packungsbestandteile Galenic Form Dry substance Excipiens Active Agent Dose Velmanasum Alfa 10 mg
Inactive agents Disodium Phosphate Dihydrate Glycin Mannitol Sodium Dihydrogenophosphate Dihydrate
Source Data was imported : 05.09.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
